Detalles de la búsqueda
1.
Tyrosine Hydroxylase Knockdown at the Hypothalamic Supramammillary Nucleus Area Induces Obesity and Glucose Intolerance.
Neuroendocrinology
; 114(5): 483-510, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38128505
2.
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
Int J Mol Sci
; 24(17)2023 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686060
3.
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
Int J Mol Sci
; 23(16)2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36012132
4.
Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
Int J Mol Sci
; 22(11)2021 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34200262
5.
Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.
Am J Physiol Endocrinol Metab
; 319(1): E133-E145, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32459527
6.
Activation State of the Supramammillary Nucleus Regulates Body Composition and Peripheral Fuel Metabolism.
Neuroscience
; 466: 125-147, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991623
7.
Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats.
Diabetol Metab Syndr
; 13(1): 11, 2021 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33485386
8.
Circadian-timed dopamine agonist treatment reverses high-fat diet-induced diabetogenic shift in ventromedial hypothalamic glucose sensing.
Endocrinol Diabetes Metab
; 3(3): e00139, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32704560
9.
Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus.
Endocrinol Diabetes Metab
; 3(1): e00101, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922028
10.
Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.
Postgrad Med
; 129(4): 446-455, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28374645
11.
Bromocriptine-QR therapy for the management of type 2 diabetes mellitus: developmental basis and therapeutic profile summary.
Expert Rev Endocrinol Metab
; 11(2): 113-148, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30058874
12.
Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin.
Postgrad Med
; 128(8): 761-769, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27687032
13.
Erratum: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.
Diabetol Metab Syndr
; 7: 61, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26273326
14.
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
J Diabetes Res
; 2015: 157698, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26060823
15.
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats.
Diabetol Metab Syndr
; 6: 104, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25937836
16.
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.
J Am Heart Assoc
; 1(5): e002279, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23316290
17.
Effect of bromocriptine-QR on glycemic control in subjects with uncontrolled hyperglycemia on one or two oral anti-diabetes agents.
Endocr Pract
; 18(6): 931-43, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23186965
18.
Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes.
Diabetes Care
; 39(10): 1846, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660123
19.
Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes.
Diabetes Care
; 33(7): 1503-8, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20332352
Resultados
1 -
19
de 19
1
Próxima >
>>